Results 91 to 100 of about 1,058 (107)
Some of the next articles are maybe not open access.
Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy ...
Dennis J. Cada +2 more
openaire +1 more source
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy ...
Dennis J. Cada +2 more
openaire +1 more source
Crystal structure of raltegravir potassium, C 20 H 20 FKN 6 O 5
Powder Diffraction, 2015The crystal structure of the potassium salt of raltegravir has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional techniques. Raltegravir potassium crystallizes in space group P 2 1 /
James A. Kaduk +3 more
openaire +1 more source
Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation
Journal of Clinical Pharmacology, 2008Larissa A Wenning, Julie A Stone
exaly
Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor
Journal of Clinical Pharmacology, 2011Larissa A Wenning, Julie A Stone
exaly